Hyun-Jin Chung
Directeur Général chez STCUBE, INC.
Fortune : 203 512 $ au 31/05/2024
Profil
Hyun-Jin Chung is the Chief Executive Officer & Director of STCube, Inc. since 2013.
He was previously the Chief Executive Officer & Director of GREEN CROSS CELL Corp.
from 2010 to 2012.
Before that, he worked as a Doctor-Clinical Pathology at Seoul National University Hospital.
He holds a doctorate degree from Seoul National University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
STCUBE, INC.
0,10% | 09/11/2023 | 46 268 ( 0,10% ) | 203 512 $ | 31/05/2024 |
Postes actifs de Hyun-Jin Chung
| Sociétés | Poste | Début |
|---|---|---|
| STCUBE, INC. | Directeur Général | 29/03/2013 |
Anciens postes connus de Hyun-Jin Chung
| Sociétés | Poste | Fin |
|---|---|---|
| GREEN CROSS CELL CORPORATION | Directeur Général | 16/08/2012 |
| Seoul National University Hospital | Corporate Officer/Principal | - |
Formation de Hyun-Jin Chung
| Seoul National University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| STCUBE, INC. | Distribution Services |
| Entreprise privées | 2 |
|---|---|
GREEN CROSS CELL Corp.
 GREEN CROSS CELL Corp. BiotechnologyHealth Technology GREEN CROSS CELL Corp. engages in the provision of anti-cancer immunotherapy. It operates through the following businesses: Cancer Immunotherapy, Cord Blood Cryopreservation, and Other Services. The company was founded on September 17, 1992 and is headquartered in Yongin-si, South Korea. | Health Technology |
| Seoul National University Hospital |
